Literature DB >> 1370652

Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation.

K A Han1, M F Kulesz-Martin.   

Abstract

An epidermal cell model in which initiated, benign tumor-producing and carcinoma stages were derived from a cloned parental cell strain was used to examine p53 expression during multistage epithelial carcinogenesis. Increased steady-state levels of p53 RNA were detected in squamous cell carcinomas compared to papilloma and normal epidermal cells. Nontumorigenic initiated cell precursors of the carcinomas exhibited normal p53 expression, localizing altered p53 regulation to the malignant conversion stage. Immunoprecipitation and Western immunoblot analyses demonstrated elevated levels of p53 protein in the moderately differentiated carcinoma compared to normal cells, and negligible levels of p53 in the poorly differentiated carcinoma cells. Sequence analysis of p53 complementary DNA from normal and carcinoma cells revealed no mutations in the coding or 5'- and 3'-untranslated regions, suggesting a novel mechanism of p53 inactivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370652

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Alternatively spliced p53 RNA in transformed and normal cells of different tissue types.

Authors:  K A Han; M F Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

3.  A novel octopamine receptor with preferential expression in Drosophila mushroom bodies.

Authors:  K A Han; N S Millar; R L Davis
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells.

Authors:  M F Kulesz-Martin; B Lisafeld; H Huang; N D Kisiel; L Lee
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

5.  HPV and p53 in cervical cancer.

Authors:  H Y Ngan; M Stanley; S S Liu; H K Ma
Journal:  Genitourin Med       Date:  1994-06

6.  Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells.

Authors:  M Li; F L Gu; W B Li; Y S Song; A R Zhou; Y L Guo
Journal:  Urol Res       Date:  1995

7.  Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.

Authors:  A Wee; M Teh; G C Raju
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

8.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection.

Authors:  A Wee; M Teh; G C Raju
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

10.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

Authors:  S Bosari; G Viale; M Roncalli; D Graziani; G Borsani; A K Lee; G Coggi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.